A potential new antipsychotic medication with a different mechanism of action may help expand treatment options for people with schizophrenia.
Xanomeline-trospium has shown promising results in clinical trials and has a unique mechanism of action.
Participants were randomly assigned to receive either KarXT or placebo orally twice a day for five weeks. Symptoms of schizophrenia were measured at screening, baseline, and weekly during the study with the Positive and Negative Syndrome Scale , a research instrument commonly used in studies of schizophrenia. The primary endpoint of the study was the change in total PANSS scores from baseline to week 5. Positive and negative symptoms were also followed using PANSS subscales.
Was KarXT beneficial? A meaningful response was defined as a 30 percent or greater reduction in total PANSS score by week 5. Using this definition, 55 percent of persons on KarXT responded versus 28 percent on placebo. This difference was both statistically significant and clinically meaningful. Importantly, both positive and negative symptoms improved. The difference between KarXT and placebo was evident by three weeks and further increased at five weeks.
Side effects were primarily gastrointestinal and occurred in both the KarXT and placebo groups, although they were higher in the KarXT group. The rates of serious or severe adverse events were low and occurred in both treatment groups to about the same degree. The effects of KarXT on cognitive symptoms were not reported in this study. However, earlier results suggested that KarXT may also improve cognitive symptoms.This is the first phase-3 study of KarXT. A second study is ongoing. Furthermore, longer studies examining results beyond five weeks are in progress. Should these additional studies replicate the findings of the Kaul et al.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Certain Low-Carb Diets May Not Lead to Weight Loss, Study FindsA study found that people who ate a meat-based low-carb diet gained more weight over time compared to those who followed a plant-based version. Experts explain the findings.
Lire la suite »
Climate Change May Affect Australians' Reproductive Health, Study FindsA new study conducted by Curtin University in Western Australia reveals a possible link between extreme bioclimatic exposure during pregnancy and babies' birthweights for gestational age. The study examined over 385,000 pregnancies between 2000 and 2015, focusing on the relationship between low and high birthweights and outdoor heat or cold stress exposures during pregnancy.
Lire la suite »
Binance Study Reveals Gender Disparity in Blockchain Startup FundingBinance has released a study analyzing the latest trends in the blockchain startup funding landscape and their influence on gender-based disparity in investment patterns. The study highlights the gap in funding received by male and female-led startups and provides insights into potential solutions for gender inequality in the industry.
Lire la suite »
Traumatic Brain Injury Linked to Cardiovascular Disease, Study FindsA study has found a surprising connection between traumatic brain injury (TBI) and cardiovascular disease (CVD). Individuals with TBI are at an elevated risk of unfavorable cardiovascular outcomes for an extended period following the initial incident. Regular monitoring and implementing strategies to mitigate cardiovascular disease risk are crucial for healthcare practitioners.
Lire la suite »